| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 103 |
| 1 | METHOTREXATE SODIUM | 102 |
| 2 | ETANERCEPT | 97 |
| 3 | METHOTREXATE | 91 |
| 4 | RITUXIMAB | 83 |
| 5 | HYDROXYCHLOROQUINE | 63 |
| 6 | HYDROXYCHLOROQUINE SULFATE | 63 |
| 7 | PREDNISONE | 63 |
| 8 | INFLIXIMAB | 53 |
| 9 | PREGABALIN | 51 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 36 | 0.0062 |
| 1 | PIROXICAM | 35 | 0.0055 |
| 2 | LANADELUMAB-FLYO | 17 | 0.0053 |
| 3 | ICATIBANT ACETATE | 20 | 0.0033 |
| 4 | GOLIMUMAB | 36 | 0.0029 |
| 5 | INFLIXIMAB-DYYB | 5 | 0.0015 |
| 6 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 7 | 0.0010 |
| 7 | OFLOXACIN OTIC SOLUTION | 7 | 0.0010 |
| 8 | OFLOXACIN OTIC | 7 | 0.0010 |
| 9 | OFLOXACIN | 7 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 117 |
| 1 | Corticosteroid [EPC] | 111 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 90 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 89 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 84 |
| 5 | Benzodiazepine [EPC] | 47 |
| 6 | Antirheumatic Agent [EPC] | 43 |
| 7 | Purine Antimetabolite [EPC] | 42 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 39 |
| 9 | Aminosalicylate [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 17 | 0.0071 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 3 | Human C1 Esterase Inhibitor [EPC] | 4 | 0.0010 |
| 4 | Quinolone Antimicrobial [EPC] | 7 | 0.0007 |
| 5 | Thymic Stromal Lymphopoietin Blocker [EPC] | 4 | 0.0006 |
| 6 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 7 | Anticholinergic [EPC] | 8 | 0.0005 |
| 8 | Somatostatin Analog [EPC] | 3 | 0.0004 |
| 9 | Purine Antimetabolite [EPC] | 42 | 0.0004 |